3IK3

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2009-11-03	Initial release
1.1	2011-07-13		Version format compliance
1.2	2021-10-13		Database references, Derived calculations, Structure summary	chem_comp, database_2, entity, pdbx_entity_nonpoly, struct_ref_seq_dif, struct_site
1.3	2023-09-06		Data collection, Refinement description	chem_comp_atom, chem_comp_bond, pdbx_initial_refinement_model	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.